Literature DB >> 33418239

The role of Th17 cells in viral infections.

Parisa Shiri Aghbash1, Nima Hemmat2, Javid Sadri Nahand3, Ali Shamekh4, Mohammad Yousef Memar5, Abouzar Babaei6, Hossein Bannazadeh Baghi7.   

Abstract

The present review provides an overview of recent advances regarding the function of Th17 cells and their produced cytokines in the progression of viral diseases. Viral infections alone do not lead to virus-induced malignancies, as both genetic and host safety factors are also involved in the occurrence of malignancies. Acquired immune responses, through the differentiation of Th17 cells, form the novel components of the Th17 cell pathway when reacting with viral infections all the way from the beginning to its final stages. As a result, instead of inducing the right immune responses, these events lead to the suppression of the immune system. In fact, the responses from Th17 cells during persistent viral infections causes chronic inflammation through the production of IL-17 and other cytokines which provide a favorable environment for tumor growth and its development. Additionally, during the past decade, these cells have been understood to be involved in tumor progression and metastasis. However, further research is required to understand Th17 cells' immune mechanisms in the vast variety of viral diseases. This review aims to determine the roles and effects of the immune system, especially Th17 cells, in the progression of viral diseases; which can be highly beneficial for the diagnosis and treatment of these infections.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IL-17; Th17; Viral infection; Virus-induced cancers

Mesh:

Year:  2021        PMID: 33418239     DOI: 10.1016/j.intimp.2020.107331

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  9 in total

Review 1.  Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade.

Authors:  Mohaddeseh Bahmani; Rojin Chegini; Elham Ghanbari; Elham Sheykhsaran; Parisa Shiri Aghbash; Hamed Ebrahimzadeh Leylabadlo; Ehsan Moradian; Amir Masoud Kazemzadeh Houjaghan; Hossein Bannazadeh Baghi
Journal:  World J Virol       Date:  2022-05-25

Review 2.  SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.

Authors:  Parisa Shiri Aghbash; Narges Eslami; Ali Shamekh; Taher Entezari-Maleki; Hossein Bannazadeh Baghi
Journal:  Life Sci       Date:  2021-01-27       Impact factor: 6.780

3.  Involvement of Th1Th17 Cell Subpopulations in the Immune Responses of Mothers Who Gave Birth to Children with Congenital Zika Syndrome (CZS).

Authors:  Iury Amancio Paiva; Débora Familiar-Macedo; Jéssica Badolato-Corrêa; Fabiana Rabe Carvalho; Helver Gonçalves Dias; Alex Pauvolid-Corrêa; Caroline Fernandes Dos Santos; Andréa Alice Silva; Elzinandes Leal de Azeredo; Renata Artimos de Oliveira Vianna; Claudete Aparecida Araújo Cardoso; Alba Grifoni; Alessandro Sette; Daniela Weiskopf; Luzia Maria de-Oliveira-Pinto
Journal:  Viruses       Date:  2022-01-26       Impact factor: 5.048

Review 4.  SARS-CoV-2: Receptor and Co-receptor Tropism Probability.

Authors:  Narges Eslami; Parisa Shiri Aghbash; Ali Shamekh; Taher Entezari-Maleki; Javid Sadri Nahand; Abolfazl Jafari Sales; Hossein Bannazadeh Baghi
Journal:  Curr Microbiol       Date:  2022-03-16       Impact factor: 2.343

Review 5.  Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review).

Authors:  Tao Yang; Huaying Huang; Longfeng Jiang; Jun Li
Journal:  Int J Mol Med       Date:  2022-07-20       Impact factor: 5.314

6.  The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection Duration.

Authors:  Kendra M Quicke; Bridget A Baxter; Sophia Stromberg; Emily N Gallichotte; Emily Fitzmeyer; Michael C Young; Kristy L Pabilonia; Nicole Ehrhart; Julie Dunn; Gregory D Ebel; Elizabeth P Ryan
Journal:  Adv Virol       Date:  2022-08-08

Review 7.  Th17 Cells in Viral Infections-Friend or Foe?

Authors:  Iury Amancio Paiva; Jéssica Badolato-Corrêa; Débora Familiar-Macedo; Luzia Maria de-Oliveira-Pinto
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

Review 8.  Viral coinfections in COVID-19.

Authors:  Parisa S Aghbash; Narges Eslami; Milad Shirvaliloo; Hossein B Baghi
Journal:  J Med Virol       Date:  2021-06-12       Impact factor: 20.693

Review 9.  The role of antigen-presenting cells in the pathogenesis of COVID-19.

Authors:  Rana Farzi; Parisa Shiri Aghbash; Narges Eslami; Arezou Azadi; Ali Shamekh; Nima Hemmat; Taher Entezari-Maleki; Hossein Bannazadeh Baghi
Journal:  Pathol Res Pract       Date:  2022-03-23       Impact factor: 3.309

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.